Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
13.84
-0.43 (-3.01%)
At close: Apr 28, 2026, 4:00 PM EDT
13.51
-0.33 (-2.38%)
After-hours: Apr 28, 2026, 5:33 PM EDT
Trevi Therapeutics Employees
Trevi Therapeutics had 34 employees as of December 31, 2025. The number of employees increased by 8 or 30.77% compared to the previous year.
Employees
34
Change (1Y)
8
Growth (1Y)
30.77%
Revenue / Employee
n/a
Profits / Employee
-$1,257,618
Market Cap
1.94B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Galapagos NV | 558 |
| Vericel | 398 |
| Ocular Therapeutix | 325 |
| Syndax Pharmaceuticals | 298 |
| Zymeworks | 264 |
| Capricor Therapeutics | 231 |
| Stoke Therapeutics | 170 |
| Pharvaris | 129 |
TRVI News
- 5 days ago - Trevi Therapeutics to Participate in Upcoming May Events - GlobeNewsWire
- 8 days ago - Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares - GlobeNewsWire
- 11 days ago - What's Going On With Trevi Therapeutics Stock? - Benzinga
- 11 days ago - Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 12 days ago - Trevi Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 27 days ago - Trevi Therapeutics to Participate in Upcoming Events - GlobeNewsWire
- 6 weeks ago - Trevi Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates - GlobeNewsWire